ARTICLE | Company News
Rigel, Albany Molecular in optimization deal
May 31, 2001 7:00 AM UTC
AMRI will provide RIGL with medicinal chemistry services for RIGL's mast cell program in asthma and allergy. RIGL is developing small molecule inhibitors of secreted inflammatory factors. RIGL will pr...